Mylan Launches Generic Fortamet

The treatment is indicated as an adjunct to diet and exercise to improve glycemic control in adults with T2DM
The treatment is indicated as an adjunct to diet and exercise to improve glycemic control in adults with T2DM

Mylan announced that it has received final approval from the Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Metformin Hydrochloride Extended-Release Tablets USP, the generic version of Fortamet (Watson).

The treatment is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is available in 500mg and 1000mg dosage strengths.

Related Articles

Metformin hydrochloride, a biguanide, reduces hepatic glucose production and intestinal glucose absorption. It also improves insulin sensitivity and peripheral glucose uptake and utilization. 

For more information call 724-514-1968 or visit Mylan.com.

Loading links....